- Home
- EAD vs SRPT Comparison
EAD vs SRPT Comparison
Compare EAD & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EAD
- SRPT
- Stock Information
- Founded
- EAD 2003
- SRPT 1980
- Country
- EAD United States
- SRPT United States
- Employees
- EAD N/A
- SRPT N/A
- Industry
- EAD Finance/Investors Services
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- EAD Finance
- SRPT Health Care
- Exchange
- EAD Nasdaq
- SRPT Nasdaq
- Market Cap
- EAD 419.0M
- SRPT 2.0B
- IPO Year
- EAD N/A
- SRPT 1997
- Fundamental
- Price
- EAD $7.09
- SRPT $17.48
- Analyst Decision
- EAD
- SRPT Hold
- Analyst Count
- EAD 0
- SRPT 31
- Target Price
- EAD N/A
- SRPT $40.61
- AVG Volume (30 Days)
- EAD 178.9K
- SRPT 7.8M
- Earning Date
- EAD 01-01-0001
- SRPT 11-05-2025
- Dividend Yield
- EAD 8.91%
- SRPT N/A
- EPS Growth
- EAD N/A
- SRPT N/A
- EPS
- EAD N/A
- SRPT N/A
- Revenue
- EAD N/A
- SRPT $2,481,531,000.00
- Revenue This Year
- EAD N/A
- SRPT $10.78
- Revenue Next Year
- EAD N/A
- SRPT N/A
- P/E Ratio
- EAD N/A
- SRPT N/A
- Revenue Growth
- EAD N/A
- SRPT 64.89
- 52 Week Low
- EAD $5.69
- SRPT $10.42
- 52 Week High
- EAD $6.81
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- EAD 51.84
- SRPT 44.35
- Support Level
- EAD $7.07
- SRPT $16.85
- Resistance Level
- EAD $7.15
- SRPT $19.27
- Average True Range (ATR)
- EAD 0.03
- SRPT 0.93
- MACD
- EAD -0.00
- SRPT -0.13
- Stochastic Oscillator
- EAD 36.67
- SRPT 22.79
About EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.